Ryan Cole
Patrimonio netto: 2 M $ in data 30/09/2026
Patrimonio netto: 2 M $ in data 30/09/2026
Mr. Ryan Cole, CPA, is a Chief Operating Officer at Tang Capital Acquisition Corp., a Chief Operating Officer at Kezar Life Sciences, Inc. and a Chief Operating Officer at Aurinia Pharmaceuticals, Inc. Mr. Cole was previously employed as a Senior Vice President-Operations by Odonate, Inc. and a Senior Auditor by Ernst & Young LLP.
He received his undergraduate degree from Santa Clara University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 18/05/2026 | 116.144 ( 0,09% ) | 2 M $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Direttore operativo | 23/03/2026 |
| KEZAR LIFE SCIENCES, INC. | Direttore operativo | 11/05/2026 |
| Società | Posizione | Fine |
|---|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Comptroller/Controller/Auditor | 01/05/2012 |
| ODONATE, INC. | Direttore operativo | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Santa Clara University
Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aurinia Pharmaceuticals, Inc.
Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Kezar Life Sciences, Inc.
Kezar Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapies targeting protein homeostasis | Health Technology |
Odonate, Inc.
Odonate, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer treatment | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale